
A new study that tested live SARS-CoV-2 against blood samples in a laboratory setting is suggesting that those who survive a breakthrough infection may have some sort of ‘super immunity’ against variants.

A new study that tested live SARS-CoV-2 against blood samples in a laboratory setting is suggesting that those who survive a breakthrough infection may have some sort of ‘super immunity’ against variants.